Target intelligence / Profile preview

Glutamate receptor ionotropic, NMDA 2C subunit (GluN2C (also GRIN2C, based on gene symbol))

Target
GluN2C (also GRIN2C, based on gene symbol)
Molecular classification
Ion channel, Receptor, Ligand-gated cation channel, Ionotropic glutamate receptor
01

Overview

The Glutamate receptor ionotropic, NMDA 2C subunit (GluN2C/GRIN2C) is encoded by the GRIN2C gene and forms part of the heterotetrameric NMDA receptor complex in the brain[5][6]. These receptors are ligand-gated ion channels that mediate excitatory synaptic transmission by permitting calcium and sodium influx upon activation by glutamate and co-agonist glycine or D-serine[1][6]. The GluN2C subunit is critical for the receptor's ion selectivity, gating characteristics, and pharmacological profile. NMDA receptor dysfunctions have been linked to a variety of neurological and psychiatric diseases, making GluN2C a therapeutic target and focal point in drug development[3][5][6].

Other names
GRIN2C (gene name)GluN2C (protein name)N-methyl-D-aspartate receptor subunit 2C
02

Mechanism of action

NMDA receptor antagonists block glutamate binding or channel opening, inhibiting excitatory neurotransmission\nChannel blockers inhibit Ca²⁺ influx through the receptor channel

03

Biological functions

Signal transductionSynaptic transmissionExcitatory neurotransmissionCalcium ion permeabilityMediation of neuronal plasticity
04

Disease associations

Neurodegenerative diseaseSchizophrenia (genetic associations)Epilepsy (genetic associations)Cognitive disorders (due to abnormal neurotransmission)
05

Safety considerations

CNS side effects: hallucinations, confusion (with antagonists such as ketamine)Excitotoxicity from overactivation (high Ca²⁺ influx, neuronal damage)Risk of cognitive impairment with long-term inhibition
06

Interacting drugs

Memantine

3 more in the full profile.

07

Biomarkers

GRIN2C gene expression/mutation may be used as biomarkers for neurological disease susceptibility or progressionChanges in NMDA receptor function and calcium channel activity may serve as efficacy indicators in CNS disorders

Beyond the preview

Go deeper on Glutamate receptor ionotropic, NMDA 2C subunit (GluN2C (also GRIN2C, based on gene symbol)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic, NMDA 2C subunit (GluN2C (also GRIN2C, based on gene symbol)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call